Multi-center survey of edaravone treatment in children

No To Hattatsu

Volumn 40, Issue 4, 2008, Pages 333-334

  Yamamoto, H ^a   Hayashi, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NORPHENAZONE;

ARTICLE; BRAIN DISEASE; HEALTH SURVEY; HUMAN; LACTIC ACIDOSIS; MITOCHONDRIAL MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING;

ANTIPYRINE; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; DRUG UTILIZATION; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; INFANT; JAPAN; MALE;

EID: 47649108289     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Edaravone Acute Brain Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003;15:222-9.
2. Yoshino H, Kimura A. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study). Amyotroph Lateral Scler 2006;7:241-5.
3. Fukuda M, Yamauchi H, Yamamoto H, et al. The evaluation of oxidative DNA damage in children with brain damage using 8-hydroxydeoxyguanosine levels. Brain Dev 2008;30:131-6.
4. Japanese source
5. Nakagomi T, Yamakawa K, Sasaki T, Saito I, Takakura K. Effect of edaravone on cerebral vasospasms following experimental subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 2003;12:17-21.
6. Japanese source